<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-sub-section" /><meta name="keywords" content="Cephalosporins; Cefuroxime; Cefotaxime; Ceftazidime; Ceftriaxone; Pseudomonas aeruginosa infections: cephalosporins, in; Ceftriaxone; Cefalexin; Cefradine; Cefadroxil; Cefaclor; Cefuroxime axetil; Cefixime; Cefpodoxime" /><meta name="IX" content="Cephalosporins; Cefuroxime; Cefotaxime; Ceftazidime; Ceftriaxone; Pseudomonas aeruginosa infections: cephalosporins, in; Ceftriaxone; Cefalexin; Cefradine; Cefadroxil; Cefaclor; Cefuroxime axetil; Cefixime; Cefpodoxime" /><title>5.1.2.1 Cephalosporins: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="201577.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="201577.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=201577.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2071.htm">5 Infections</a> &gt; <a href="3705.htm">5.1 Antibacterial drugs</a> &gt; <a href="3761.htm">5.1.2 Cephalosporins, carbapenems, and other beta-lactams</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="3761.htm" title="Previous: 5.1.2 Cephalosporins, carbapenems, and other beta-lactams">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="3763.htm" title="Next: CEFACLOR">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_201577">5.1.2.1 Cephalosporins</h1><?highlighter on?><div id="pC" class="jN"><div><p>The cephalosporins are broad-spectrum <span>antibiotics</span> which
are used for the treatment of septicaemia, pneumonia, meningitis,
biliary-tract infections, peritonitis, and urinary-tract infections.
The pharmacology of the cephalosporins is similar to that of the penicillins,
excretion being principally renal. Cephalosporins penetrate the cerebrospinal
fluid poorly unless the meninges are inflamed; <span>cefotaxime</span> is a suitable cephalosporin for infections of the CNS (e.g meningitis).</p><div id="_200855"><p>The principal side-effect of the cephalosporins is hypersensitivity
and about 0.5–6.5% of penicillin-sensitive patients will also be allergic
to the cephalosporins. Patients with a history of immediate hypersensitivity
to penicillin should not receive a cephalosporin. If a cephalosporin
is essential in these patients because a suitable alternative antibacterial
is not available, then cefixime, cefotaxime, ceftazidime, ceftriaxone,
or cefuroxime can be used with caution; cefaclor, cefadroxil, cefalexin,
and cefradine should be avoided.<span id="_201068"></span><span id="_201069"></span></p></div><p>Antibiotic-associated colitis may occur with
the use of broad-spectrum cephalosporins, particularly second- and
third-generation cephalosporins.</p><p><b><span>Cefuroxime</span></b> is a ‘second generation’ cephalosporin
that is less susceptible than the earlier cephalosporins to inactivation
by beta-lactamases. It is, therefore, active against certain bacteria
which are resistant to the other drugs and has greater activity against <span class="cAC">Haemophilus influenzae</span>.</p><p><b><span>Cefotaxime</span></b>, <b><span>ceftazidime</span></b> and <b><span>ceftriaxone</span></b> are ‘third generation’ cephalosporins with greater activity
than the ‘second generation’ cephalosporins against certain Gram-negative
bacteria. However, they are less active than <span>cefuroxime</span> against Gram-positive bacteria, most notably <span class="cAC">Staphylococcus
aureus</span>. Their broad antibacterial spectrum may encourage
superinfection with resistant bacteria or fungi. </p><p><b><span>Ceftazidime</span></b> has good activity
against pseudomonas. It is also
active against other Gram-negative bacteria.</p><p><b><span>Ceftriaxone</span></b> has a longer half-life and therefore
needs to be given only once daily. Indications include serious infections
such as septicaemia, pneumonia, and meningitis. The calcium salt of <span>ceftriaxone</span> forms a precipitate in the gall bladder which
may rarely cause symptoms but these usually resolve when the antibiotic
is stopped.</p><div class="cAZ"><h2>Orally active cephalosporins</h2> <p class="cAX">The orally active
‘first generation’ cephalosporins, <b><span>cefalexin</span></b>, <b><span>cefradine</span></b>, and <b><span>cefadroxil</span></b> and the ‘second generation’ cephalosporin, <b><span>cefaclor</span></b>, have a similar antimicrobial spectrum. They are useful
for urinary-tract infections which do not respond to other drugs or
which occur in pregnancy, respiratory-tract infections, otitis media,
sinusitis, and skin and soft-tissue infections. <span>Cefaclor</span> has good activity against <span class="cAC">H. influenzae</span>, but
it is associated with protracted skin reactions especially in children. <span>Cefadroxil</span> has a long duration of action and can be given
twice daily; it has poor activity against <span class="cAC">H. influenzae</span>. <b><span>Cefuroxime</span> axetil</b>, an ester of the ‘second generation’
cephalosporin <span>cefuroxime</span>, has the same antibacterial
spectrum as the parent compound;  it is poorly absorbed.</p><p><b><span>Cefixime</span></b> and <b><span>cefpodoxime</span> proxetil</b> are orally
active ‘third generation’ cephalosporins. <span>Cefixime</span> has a longer duration of action than the other cephalosporins that
are active by mouth. It is only licensed for acute infections. <span>Cefpodoxime</span> proxetil is more active than the other oral
cephalosporins against respiratory bacterial pathogens and it is licensed
for upper and lower respiratory-tract infections.</p></div><p>For treatment of Lyme disease, see <a title="sub-sub-section: Broad-spectrum penicillins" href="3723.htm#_3723">section 5.1.1.3</a>.</p><div id="_3762.2"><div class="cAZ"><h2>Oral infections</h2> <p class="cAX">The <span>cephalosporins</span> offer little advantage over the <span>penicillins</span> in
dental infections, often being less active against anaerobes. Infections
due to oral streptococci (often termed viridans streptococci) which
become resistant to <span>penicillin</span> are usually also
resistant to <span>cephalosporins</span>. This is of importance
in the case of patients who have had rheumatic fever and are on long-term <span>penicillin</span> therapy. <span>Cefalexin</span> and <span>cefradine</span> have been used in the treatment of oral infections.</p></div></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_3763"><a href="3763.htm" title="CEFACLOR">CEFACLOR</a></li><li id="_3766"><a href="3766.htm" title="CEFADROXIL">CEFADROXIL</a></li><li id="_3789"><a href="3789.htm" title="CEFALEXIN">CEFALEXIN</a></li><li id="_3768"><a href="3768.htm" title="CEFIXIME">CEFIXIME</a></li><li id="_3772"><a href="3772.htm" title="CEFOTAXIME">CEFOTAXIME</a></li><li id="_3776"><a href="3776.htm" title="CEFPODOXIME">CEFPODOXIME</a></li><li id="_3797"><a href="3797.htm" title="CEFRADINE">CEFRADINE</a></li><li id="_3780"><a href="3780.htm" title="CEFTAZIDIME">CEFTAZIDIME</a></li><li id="_3784"><a href="3784.htm" title="CEFTRIAXONE">CEFTRIAXONE</a></li><li id="_3786"><a href="3786.htm" title="CEFUROXIME">CEFUROXIME</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="3761.htm">Previous: 5.1.2 Cephalosporins, carbapenems, and other beta-lactams</a> | <a class="top" href="201577.htm#">Top</a> | <a accesskey="]" href="3763.htm">Next: CEFACLOR</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>